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Flora Guillot1,2, Alexandra Garcia1,3, Marion Salou1,2, Sophie Brouard1,2,3, David A. Laplaud1,2,4 and Arnaud B. Nicot1,2*Abstract
Background: Astrocytes, the most abundant cell population in mammal central nervous system (CNS), contribute
to a variety of functions including homeostasis, metabolism, synapse formation, and myelin maintenance. White
matter (WM) reactive astrocytes are important players in amplifying autoimmune demyelination and may exhibit
different changes in transcriptome profiles and cell function in a disease-context dependent manner. However, their
transcriptomic profile has not yet been defined because they are difficult to purify, compared to gray matter
astrocytes. Here, we isolated WM astrocytes by laser capture microdissection (LCM) in a murine model of multiple
sclerosis to better define their molecular profile focusing on selected genes related to inflammation. Based on
previous data indicating anti-inflammatory effects of estrogen only at high nanomolar doses, we also examined
mRNA expression for enzymes involved in steroid inactivation.
Methods: Experimental autoimmune encephalomyelitis (EAE) was induced in female C57BL6 mice with MOG35–55
immunization. Fluorescence activated cell sorting (FACS) analysis of a portion of individual spinal cords at peak
disease was used to assess the composition of immune cell infiltrates. Using custom Taqman low-density-array
(TLDA), we analyzed mRNA expression of 40 selected genes from immuno-labeled laser-microdissected WM astrocytes
from lumbar spinal cord sections of EAE and control mice. Immunohistochemistry and double immunofluorescence on
control and EAE mouse spinal cord sections were used to confirm protein expression in astrocytes.
Results: The spinal cords of EAE mice were infiltrated mostly by effector/memory T CD4+ cells and macrophages.
TLDA-based profiling of LCM-astrocytes identified EAE-induced gene expression of cytokines and chemokines as well as
inflammatory mediators recently described in gray matter reactive astrocytes in other murine CNS disease models.
Strikingly, SULT1A1, but not other members of the sulfotransferase family, was expressed in WM spinal cord astrocytes.
Moreover, its expression was further increased in EAE. Immunohistochemistry on spinal cord tissues confirmed
preferential expression of this enzyme in WM astrocytic processes but not in gray matter astrocytes.
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Conclusions: We described here for the first time the mRNA expression of several genes in WM astrocytes in a
mouse model of multiple sclerosis. Besides expected pro-inflammatory chemokines and specific inflammatory
mediators increased during EAE, we evidenced relative high astrocytic expression of the cytoplasmic enzyme
SULT1A1. As the sulfonation activity of SULT1A1 inactivates estradiol among other phenolic substrates, its high
astrocytic expression may account for the relative resistance of this cell population to the anti-neuroinflammatory
effects of estradiol. Blocking the activity of this enzyme during neuroinflammation may thus help the injured CNS
to maintain the anti-inflammatory activity of endogenous estrogens or limit the dose of estrogen co-regimens for
therapeutical purposes.
Keywords: Multiple sclerosis, Fibrous astrocyte, Radial glia, Astrogliosis, Estrogen metabolismBackground
Astrocytes are situated in key positions between microves-
sels, axons, and oligodendrocytes where they participate in
a wide range of functions during brain construction and
maintenance, exchanging signals with the neuronal com-
partment at the synapse, maintaining low extracellular
glutamate level preventing chronic glutamate excitotoxi-
city, and supplying substrates for energy metabolism to
neurons and oligodendrocytes [1]. Astrocytes also have
the potential to secrete a variety of signaling molecules, in-
cluding growth factors for neurons and oligodendrocytes,
immune modulators, metalloproteases, and nitric oxide
depending on cellular context. Injury, inflammation, or de-
generative disease in the central nervous system (CNS) is
accompanied by alterations in the morphology of astro-
cytes, a response referred to as reactive astrogliosis. The
positive effect of the astrogliotic response was initially il-
lustrated using mice in which early reactive proliferative
astrocytes were selectively targeted for ablation in the in-
jured CNS [2]. On the other hand, the detrimental role of
reactive astrocytes involving NFkB signaling was clearly
demonstrated in in vivo models of neuroinflammation, in-
dicating they have a key role in the local inflammatory re-
sponse [3] and in remyelination [4]. Thus, in addition to
axonal damage and demyelination, astrocytic activation is
a central pathological feature that likely contributes to
multiple sclerosis progression, in relapsing-remitting as
well as in progressive forms with low grade inflammation
[5]. Previous studies using transcriptomics of experimental
autoimmune encephalomyelitis (EAE) and multiple scler-
osis (MS) lesions have provided important insights in the
pathogenesis and potential new targets for therapy [6–8].
Comparing the transcriptomes of whole CNS tissues is a
useful strategy for pinpointing specific alterations in CNS
diseases. However, this approach needs to be completed
by histological approaches to localize the cellular source of
identified molecules and their potential targets. Thus, one
factor limiting the interpretation of tissue-based transcrip-
tomic data is the lack of cell-type purity. Laser capture mi-
crodissection (LCM) following immunolabeling is useful
for overcoming this limitation [9]. Direct mRNA profilingfor a single cell population from frozen brain tissue slices
is now possible. Here, we applied this strategy to
characterize the molecular profile of white matter astro-
cytes in EAE spinal cord. This approach is especially
needed for this astrocyte population because it cannot be
purified by flow cytometry-based methods in contrast to
cortical gray matter astrocytes [10]. Indeed, the use of
astrocyte-specific GFP transgenic mice and Fluorescence
activated cell sorting (FACS) analysis has facilitated gene
expression profiling of cortical astrocytes in two animal
models of CNS injury indicating that astrocytes may ex-
hibit two types of reactive profile (deleterious or protect-
ive) depending on the disease models [11]. Similarly, a
better identification of the molecular signature of reactive
white matter astrocytes in CNS tissue infiltrated by im-
mune cells is a prerequisite for further designing in vitro
and in vivo experiments in order to better understand the
contribution of astrocytes in multiple sclerosis physiopa-
thology. Using a murine model of multiple sclerosis, ex-
perimental autoimmune encephalomyelitis, we employed
LCM-astrocytes from spinal cord fresh-frozen sections to
determine transcript expression levels of various genes
that have been recently highlighted in normal [10] or re-
active [11] gray matter astrocytes. Whereas low levels of
endogenous estrogen prevent microglial reactivity [12], we
and others have found that only high nanomolar levels of
estrogen are able to dampen ongoing EAE and neuroin-
flammation in vivo as well as in vitro to reduce astrocytic
pro-inflammatory cytokines or chemokines in vitro [13].
We thus also examined the expression of sulfotransferases
and glucuronidases, cytoplasmic enzymes involved in es-
trogen inactivation by conjugation [14].
Materials and methods
Induction of active EAE
Three adult female mice (8 weeks old, Janvier Labs,
France) were immunized subcutaneous (s.c.) at the base
of the tail and lower flanks with 200 μg of MOG35–55
peptide (MEVGWYRSPFSRVVHLYRNGK, purity >85 %,
Genecust Europe, France) in phosphate buffered saline
(PBS) emulsified with an equal part of complete Freund’s
Table 1 List of antibodies used for FACS analysis with their
corresponding targets
Antibody Targets




Anti-CD3 T cells (with anti-CD4 for CD4 T cells;
with anti-CD8 for CD8 T cells)
Anti-B220 Cells of the B cell lineage
Anti-CD19 Cells of the B cell lineage (high level
before plasma blast stage)
Anti-CD44 Memory/effector T cells
Anti-CD62L Naive (CD44−) and central memory
(CD44+) T cells
Anti-Ly6G Neutrophiles
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culosis H37Ra at 6 mg/ml (Difco Laboratories, Detroit,
MI, USA) as previously described [15]. Three control mice
were s.c. injected with adjuvant/PBS. Mice received 300
ng of pertussis toxin injected intraperitoneally (i.p.) on
days 0 and 2 (Calbiochem, Darmstadt, Germany). Mice
were scored daily for clinical signs of disease according to
the 0–5 scale: 0, no detectable sign; 1, complete limp tail;
2, limp tail with unilateral hindlimb paralysis; 3, bilateral
hindlimb paralysis; 4, bilateral hindlimb paralysis and fore-
limb weakness (end point). At peak of disease (score 3–4,
5–6 days after EAE onset corresponding to partial limp
tail), mice were anesthetized with thiopental and intracar-
diacally perfused with cold PBS. Spinal cords were flushed.
The lumbar part was snap-frozen and embedded in
Tissue-Tek® optimal cutting temperature (OCT) with dry
ice and stored at −80 °C and placed at −20/25 °C before
being used for LCM. The rest of the spinal cord was used
for FACS analysis.
Assessment of spinal cord immune infiltrate by FACS
analysis
Immune cell infiltrates were evaluated in individual
spinal cords according to the method adapted from [16].
Spinal cord was dilacerated and digested for 20 min in
HBBS buffer containing collagenase D (1 mg/ml), DNase
I (1 mg/ml), and MgCl2 (1 mM). Cells were dissociated
and passed through 100 μm and 70 μm filters. Cells
were then incubated with fluorescent antibody anti-
CD45 APC-Cy7 (BD 560694), anti-CD11b APC (BD
553312), anti-CD3 FITC (BD 553062), anti-CD4 A700
(BD 557956), anti-CD8 PE-Cy7 (BD 552877), anti-B220
PE (BD 553090) or anti-Ly6G PE (BD 551461), anti-
CD44 A700 (BD 560567), and anti-CD62L PerCP-Cy5.5
(BD 560513) at 1/100 for 15 min at 4 °C. Next, cells
were permeabilized with BD CytoFix/CytoPerm (554714,
Biosciences), and nuclei were labeled with DAPI (1 μg/
ml) before gating on DAPI+ immune cells (CD45high)
for FACS analysis. Table 1 recapitulates antibodies and
their cellular targets used for this study.
Preparation and staining of frozen sections for LCM
Twelve micrometer spinal cord sections were prepared
using a Leica cryostat at −17 °C and thawed onto glass
slides covered with a thin biochemically inert membrane
(MembraneSlide 0.17 PET, Zeiss, Germany). After quick
drying at room temperature, the sections were fixed in
100 % ethanol, blocked for 5 min at room temperature
in 0.01 M phosphate buffer containing 2 M NaCl (high
PBS), 25 % Normal Donkey Serum (NDS), and 0.1 %
Triton-X100. Sections were then incubated with primary
antibodies rabbit anti-glial fibrillary acidic protein (GFAP)
(1/50, DakoCytomation, Glostrup, Denmark) and rat anti-mouse CD3e (1/10, BD Pharmingen) in high PBS with 2.5
% NDS for 10 min. After two 3-min washings with high
PBS, sections were incubated with secondary antibodies
(1/50) in high PBS and 2.5 % NDS for 10 min. The
AF488-coupled F(ab′)2 secondary (anti-rabbit IgG) and
Rhodamine Red-X coupled F(ab′)2 secondary (anti-rat
IgG) from Jackson ImmunoResearch (Suffolk, England)
were used. After two 3-min washings with high PBS, sec-
tions were dipped in 70 % ethanol for 1–3 s and dehy-
drated in 100 % ethanol.
Laser capture microdissection and RNA extraction
PET-coated slides were placed face up, dried directly
after staining, and a 0.2-ml Eppendorf tube cap was
placed on the dedicated tubing rack of the UV laser mi-
crodissection PALM Microbeam (Carl Zeiss, Germany).
Samples were processed within 2 h with LCM settings as
follows: cut energy, 41; cut focus, 82; LPC energy delta,
LPC focus delta 2; and 20 μm spot distances. After
stamping CD3-immunolabeled cells at ×40 objective
under Zeiss 43HE filter set to localize T cell infiltrated
zones in the EAE white matter, contours of GFAP-
labeled astrocytes were carefully drawn at ×40 objective
using Zeiss 38HE filter set (Fig. 1a, b). White matter
GFAP-labeled astrocytes from control mice were directly
selected under the 38HE filter set. At the end of the
drawings, astrocytes were microdissected and catapulted
in the 0.2-ml Eppendorf tube cap filled with RLT lysis
buffer (RNeasy Micro kit, Qiagen, Hilden, Germany)
containing 1 % beta-mercaptoethanol. For each mouse,
~5.106 μm2 of pooled astrocytes were then extracted for
total RNA and Dnase I treated with RNeasy Micro kit.
RNA quantity and integrity were evaluated using the
2100-Bioanalyzer with the RNA 6000 Pico kit (Agilent
Technologies). Astrocyte samples (corresponding to
4000–6000 cells) gave 5–7 ng RNA. To analyze more
than a few genes, a preamplification step was thus
Fig. 1 Immunolabeled LCM-astrocytes and housekeeping gene expression. a, b Example of immunostainings of T cells and astrocytes in white
matter spinal cord (here ventrolateral part as in Fig. 3). CD3 was used to label T cells and identify immune T cell infiltrated zones (a) and GFAP to
label astrocytes (a′, b, b′). b′ shows an example of an astrocyte drawing before cutting and catapulting. Scale bar a, a′ 70 μm; b, b′, 25 μm.
c Analysis of the four housekeeping genes expressed in the LCM-dissected astrocyte control and EAE samples (n = 6, no differences between
control and EAE samples were observed except that one of six cDNA samples did not give a signal for GADPH (1)). TUB1A1 (TUB) and PPIA
probes gave the most robust signals; the geometric mean of these two reference genes was thus used for dCt calculations
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amplification of LCM samples have been shown to be
highly sensitive and reproducible [17]. The cDNA was
amplified with the CellAmp Whole Transcriptome Amp-
lification Kit (#TAK3734Z, Takara, Japan).
Taqman arrays
Custom-made Taqman array 96 well plates (Life Technolo-
gies, Foster City, CA, USA) were used for gene expression
profiling based on qPCR to compare EAE reactive astro-
cytes to control astrocytes. The list of genes and corre-
sponding probes is presented in Table 2. The Taqman
array plates were loaded with the sample-specific PCR mix
containing the template cDNA, TaqMan Universal PCR
Master Mix, and water to form the reaction mix as indi-
cated by the provider. Then, the plates were centrifuged
with two consecutive 1-min spins to ensure complete dis-
tribution of the sample-specific PCR reaction mix. The
plate was sealed and introduced into Viia7 Real-Time PCRsystem (Applied Biosystems/Life Technologies, Foster City,
CA, USA) with 40 PCR cycles and according to recom-
mended thermal cycling conditions for microfluidic cards.
To detect expression signals at the maximum sensitivity,
cycle threshold (Ct) readings were obtained using a DRn
threshold of 0.04, ensuring this was in the log-linear range
of exponential amplification for each gene and at least 10-
fold above background levels. We rated a Ct value of <38
as negative (below detection level), 38–36 as very poor,
35–30 as poor, and <30 as good. The relative expression of
each transcript was measured using the 2−ddCt method
[18]; the geometric mean of Ct values of the best reference
genes (according to [19]), alpha-tubulin 1A (TUB1A1) and
peptidylprolyl isomerase A (PPIA, cyclophilin A) (Fig. 1c),
was used for normalization of gene expression levels and
calculation of dCt values. Values are expressed as mean ±
sem. Data were analyzed using Excel and GraphPad Prism
software 5.0 using Mann–Whitney test. Differences were
considered statistically significant if the P value was <0.05.
Table 2 List of gene transcripts with their corresponding probes (ID assay)
Symbol ID assay Gene name
Arg1 Mm00475988_m1 Arginase 1
Ccl2 Mm00441242_m1 Chemokine (C-C motif) ligand 2
Ccl3 Mm00441259_g1 Chemokine (C-C motif) ligand 3
Ccl5 Mm01302427_m1 Chemokine (C-C motif) ligand 5
Ccl7 Mm00443113_m1 Chemokine (C-C motif) ligand 7
Cxcl9 Mm00434946_m1 Chemokine (C-X-C motif) ligand 9
Cxcl10 Mm00445235_m1 Chemokine (C-X-C motif) ligand 10
Cxcl12 Mm00445553_m1 Chemokine (C-X-C motif) ligand 12
Cxcl16 Mm00469712_m1 Chemokine (C-X-C motif) ligand 16
Dbi Mm00833261_g1 Diazepam binding inhibitor
Gfap Mm01253033_m1 Glial fibrillary acidic protein
Il15 Mm00434210_m1 Interleukin 15
Il15ra Mm04336046_m1 Interleukin 15 receptor, alpha chain
Il1b Mm00434228_m1 Interleukin 1 beta
Lcn2 Mm01324470_m1 Lipocalin 2
Mbp Mm01266402_m1 Myelin basic protein
Serping1 Mm00437834_m1 Serpin peptidase inhibitor, clade G, member 1
Spp1 Mm00436767_m1 Secreted phosphoprotein 1 (osteopontin)
Sult1a1 Mm00467072_m1 Sulfotransferase family 1A, phenol-preferring, member 1
Sult1c2 Mm00471849_m1 Sulfotransferase family, cytosolic, 1C, member 2
Sult1d1 Mm00502035_m1 Sulfotransferase family 1D, member 1
Sult1e1 Mm00499178_m1 Sulfotransferase family 1E, member 1
Sult2a1 Mm04205659_mH Sulfotransferase family 2A, DHEA-preferring, member 2
Sult2b1 Mm00450550_m1 Sulfotransferase family, cytosolic, 2B, member 1
Sult3a1 Mm00491057_m1 Sulfotransferase family 3A, member 1
Tgfb1 Mm01178820_m1 Transforming growth factor, beta 1
Tnf Mm00443258_m1 Tumor necrosis factor alpha
Tnfrsf9 Mm00441899_m1 Tumor necrosis factor receptor superfamily, member 9
Tnfsf9 Mm00437155_m1 Tumor necrosis factor (ligand) superfamily, member 9
Tspo Mm00437828_m1 Translocator protein
Ugt1a1 Mm02603337_m1 UDP glucuronosyltransferase 1 family, polypeptide A1
Ugt2a3 Mm00472170_m1 UDP glucuronosyltransferase 2 family, polypeptide A3
Ugt2b34 Mm00655373_m1 UDP glucuronosyltransferase 2 family, polypeptide B34
Ugt2b5 Mm01623253_s1 UDP glucuronosyltransferase 2 family, polypeptide B5
Ugt3a1 Mm01703504_mH UDP glycosyltransferases 3 family, polypeptide A1
Ugt8a Mm00495930_m1 UDP galactosyltransferase 8A
Housekeeping genes
Hprt Mm00446968_m1 Hypoxanthine guanine phosphoribosyl transferase
Ppia Mm02342430_g1 Peptidylprolyl isomerase A
Tuba1a Mm00846967_g1 Tubulin, alpha 1A
Gadph Mm99999915_g1 Glyceraldehyde-3-phosphate dehydrogenase
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For double immunofluorescence, fresh-frozen spinal
cord 12-μm thick sections from control and EAE (score
3) mice were alcohol fixed and preincubated in PBS with
25 % Normal Donkey Serum and 0.03 % Triton-X100
for 20 min at room temperature, followed by overnight
incubation at 4 °C with rat anti-GFAP (1/400, #345860,
Merck Millipore) and rabbit anti-mouse SULT1A1 (1/
400, #38411, Abcam) in PBS and 2.5 % NDS and 0.03 %
Triton-X100. After three washes in PBS, sections were
incubated for 45 min with donkey AF594- or AF488-
coupled F(ab′)2 anti-rat or anti-rabbit IgG (1:1500; Jack-
son ImmunoResearch, Suffolk, England) in PBS, 2.5 %
NDS and 0.03 % Triton-X100. Sections were incubated
with DAPI at 1 μg/ml for 5 min, rinsed, and cover-
slipped with anti-fading mounting medium (Mowiol/
DABCO). Negative controls, where anti-SULT1A1 or
anti-SULT1A1/anti-GFAP was omitted in the incubation
steps, were included in the experiment. The spinal cord
sections were analyzed on a fluorescent microscope
using appropriate filters (Nikon), and pictures were
taken at ×40 objective using a digital camera (Eclipse
DXM1200) connected to an image-acquisition software
(ACT-1, Nikon).
For DAB colorimetric immunohistochemistry, coronal
spinal cord 16-μm thick sections from paraformaldehyde-
perfused control (3) and EAE (3) mice (28 days after EAE
onset, score 1.5) were used for SULT1A1 and GFAP
immunolabeling using peroxydase/DAB amplification.
Briefly, sections were rehydrated in 0.01 M PBS, incubated
with 0.3 % H202 for 20 min, rinsed in PBS, and preincu-
bated in PBS with 25 % Normal Donkey Serum (NDS)
and 0.03 % Triton-X100 for 20 min at room temperature,
followed by overnight incubation at 4 °C with anti-mouse
SULT1A1 rabbit antibody at 1/1000 (Bioss, Woburn, MA,
USA) or at 1/400 (Abcam, #38411, Cambridge, MA, USA)
or with rabbit anti-GFAP (1/2000, Dako) in PBS and 2.5 %
NDS and 0.03 % Triton-X100. After three washes in PBS,
sections were incubated with anti-rabbit IgG donkey
biotinylated-IgG (Jackson ImmunoResearch, Suffolk,
England) for 45 min followed by three washes in PBS.
Finally, peroxydase revelation was performed using ABC
Elite kit (Vector Labs, Burlingame, CA, USA) and using
10-min DAB substrate incubation at room temperature.
Sections were then dehydrated and coverslipped with Neo-
Mount reagent (Merck Millipore, Darmstadt, Germany).
As control for SULT1A1 specificity, negative controls with
no primary antibody performed on spinal cord and kidney
sections were performed and did not give DAB stain-
ing. Female mouse kidney which contains SULT1A1-
expressing tubular cells was used as positive control for
SULT1A1 antibodies. Pictures were taken at ×40 objective
using a digital camera (Eclipse DXM1200) connected to
an image-acquisition software (ACT-1, Nikon).Results and discussion
FACS analysis of EAE infiltrates
A portion of the spinal cord from the three EAE mice
used for LCM was processed for FACS analysis of im-
mune infiltrates. The leukocyte composition is in agree-
ment with previous reports with 33 ± 8 % lymphocytes
(CD11b-), 39 ± 14 % macrophages (CD11b + Ly6G-),
and 13 ± 9 % neutrophiles (CD11b + Ly6G+). Lympho-
cytes were composed of 64 ± 4 % T cells (CD3+) with a
CD4/CD8 ratio of ~4 and 23 ± 4 % B cell lineage (B220+);
more than 80 % of T cells were CD44+ CD62L- indicat-
ing an effector/memory phenotype (Additional file 1:
Figure S1).
RNA is well preserved after the different immunolabeling
and LCM steps
In order to ensure that the immunostaining or microdis-
section steps preserved sufficient RNA, we first checked
the integrity of the RNA extracted from the whole spinal
cord coronal sections at each critical point of the proto-
col. Automatic analysis of the 28S/18S ratio using Agi-
lent microelectrophoresis indicates a good preservation
of RNAs (ratios >1.6) with our LCM protocol (Fig. 2a,
lanes 1–5). The use of high (2 M) NaCl concentration in
all immunolabeling steps was crucial to prevent loss and
degradation of the RNA (Fig. 2a, lane 6) as already men-
tioned [20]. The RNA integrity number (RIN) was superior
to 6.7 for the samples (example of a microelectrophoresis
profile in Fig. 2b) indicating relative well-preserved RNA,
whereas it dropped to 4–4.6 when high NaCl was omitted
in the incubation steps. RINs for the six LCM samples
used for TDLA were 7.4 ± 0.3, indicating good RNA
quality.
TLDA analysis
We present here a selected transcriptomic profile of 40
genes of control and EAE spinal cord white matter as-
trocytes. About 4000–6000 pooled LCM-astrocytes per
sample (corresponding to a total captured surface of 5
mm2) were needed for obtaining sufficient RNA (~5 ng).
This recovery is in the expected range for LCM-dissected
mouse cells (1–10 pg/cell; [21]). Table 3 summarizes the
expression of transcripts that was examined in this study.
All transcripts presented here were at least detected in the
mixed tissue control sample, which contains liver, spleen,
and brain cDNAs and which was used as a positive control
for the probes.
Glial markers
Expression of the astrocytic marker GFAP mRNA was
detected in all LCM samples although at fair levels with
no difference between control and EAE astrocytes. A
slight increase of almost two-fold in GFAP mRNA is
found in the spinal cord tissue of various ascending EAE
Fig. 2 Assessment of RNA integrity during immunohistochemical
steps and laser microdissection procedures. a Microelectrophoresis
of total RNA extracted from 8–12 coronal fresh-frozen spinal cord
sections: (1) directly after quick defrosting (starting material), (2) after
ethanol fixation, (3) at the end of the LCM immunohistochemistry
steps in the presence of high NaCl concentration (high PBS), (4) with
further 2 h dry at room temperature corresponding to the maximum
time needed for drawing, dissecting, and capturing astrocytes on
one slide, (5) after the microdissection of astrocytes, and (6) at the
end of immunohistochemistry steps in the presence of isotonic NaCl
concentration (normal PBS). b Example of an electrophoregram with
RIN value corresponding to (5)
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creased number of astrocytes in the white matter at EAE
onset and increased GFAP expression in gray matter as-
trocytes, which express lower levels of GFAP than white
matter astrocytes in basal conditions. Moreover, GFAPα
(the main GFAP isoform in white matter astrocytes)
mRNAs are localized all along the processes in contrast
to most mRNA concentrated around the nucleus [22].
Because LCM targeted proximal processes, it is possible
that GFAPα mRNA is underrepresented in our samples,
accounting for the lack of a detectable GFAP transcript
increase during EAE. Fair levels of MBP mRNA, specific
for oligodendrocytes, were obtained, whereas UGT8a
transcripts, also specific for the oligodendroglial popula-
tion [10], were detected either at very poor levels or not
at all. MBP mRNA, one of the most abundant tran-
scripts in the CNS, was also recovered from mouse
LCM-astrocytes in a similar study [23], suggesting that
this abundant mRNA present in nearby oligodendrocyteprocesses is easily amplified even from minute amounts
of selected astrocytes in situ.
Markers of astrocyte reactivity
Lcn2 though not specific to the astrocytic population is
now considered a good marker of reactive astrocytes be-
cause its expression is highly induced in various experi-
mental settings and CNS diseases including EAE [24–27].
It was thus used as a prototypic marker of astrocyte re-
activity. Indeed, we found this transcript highly up-
regulated in EAE samples validating the LCM approach.
We also look at arginase 1, translocator protein (TSPO)
and its ligand Diazepam Binding Inhibitor (DBI), serp-
inG1, and osteopontin (SPP1) transcripts because they
have been highlighted as differentially induced in other
models of neuroinflammation, particularly low induction
of arginase 1 with high induction of TSPO, and serpinG1
may be associated to the pro-inflammatory profile of LPS-
reactive astrocytes; in contrast, high induction of Arg1
transcripts with moderate increase in serpinG1 has been
associated to a protective astrocytic profile in murine
models of stroke, after transient middle cerebral artery oc-
clusion (MCAO) [11] or photothrombotic ischemia [28].
Indeed, very high Arg1 transcripts are found in spinal cord
tissue during murine EAE [29]. However, we found that
Arg1 mRNA was poorly expressed in white matter astro-
cytes during EAE (Table 3) indicating that astrocytes are
not a main source for arginase 1 production. Rather, dur-
ing EAE, some activated microglia or macrophages have
been shown to express high levels of arginase 1, possibly
having anti-inflammatory effects [30]. TNFα is a potent
pro-inflammatory cytokine for astrocytes. Although astro-
cytes exhibit low basal levels of this transcript, it is not up-
regulated in EAE reactive astrocytes (Table 3). The
increased TNFα expression in the CNS reported in previ-
ous EAE transcriptomic studies is rather ascribed to react-
ive microglia and infiltrated immune cells [31, 32].
Microglial TNFα is indeed highly detrimental to oligoden-
drocytes [33]. The interleukins IL-1β and IL-15 with its re-
ceptor IL15RA, as TNFSF9/4-1BBL and its receptor, were
not consistently detected in LCM-astrocytes, though they
can be expressed by cultured astrocytes in inflammatory
conditions. In EAE CNS tissue, activated microglia/macro-
phages and infiltrating lymphocytes are in fact the main
producers of IL-1β in EAE CNS tissue [34], whereas IL-15
expression is mostly endothelial and its receptor IL15RA
mostly neuronal [35, 36].
Interestingly, whereas microglia was believed to be the
main producer of TSPO, CNTF-stimulated GFAP+ mouse
striatal astrocytes [37] and reactive astrocytes in the
MCAO murine model [11] clearly overexpress the 18
kDa TSPO. The TSPO, by interacting with mitochon-
drial membrane proteins, is known to play a role in
cholesterol mitochondrial import and thus in the first
Table 3 Summary of TLDA analysis
Mix tissue LCM-astrocytes
Ct value dCt Con dCt EAE Fold increase (2−ddCt)
Gene symbol Detected in all EAE samples at poor to good levels
Arg1 25.1 14.3 ± 1.0 13.2 ± 1.5 2.2 NS ¥
Ccl2 23.3 12.0 ± 0.5 3.5 ± 0.6 349 * ¥
Ccl3 23.9 11.1 ± 2.7 11.8 ± 4.4 0.6 NS
Ccl5 18.5 12.0 ± 2.5 4.4 ± 1.1 199 * ¥
Ccl7 23.9 12.5 ± 2.1 4.6 ± 0.4 231 * ¥
Cxcl9 21.3 13.0 ± 1.7 4.9 ± 0.9 270 * ¥
Cxcl10 21.7 13.8 ± 1.1 6.1 ± 0.6 214 * ¥
Cxcl16 21.4 9.8 ± 1.9 5.0 ± 0.5 28 *
Dbi 12.8 0.7 ± 0.2 −0.2 ± 0.2 1.8 *
Gfap 24.7 9.7 ± 1.2 11.9 ± 3.0 0.2 NS
Lcn2 13.7 10.5 ± 2.9 2.5 ± 0.4 253 *
Mbp 22.1 7.9 ± 1.7 7.4 ± 1.5 1.4 NS
Serping1 16.5 11.0 ± 2.5 5.4 ± 0.3 48 *
Spp1 23.2 13.1 ± 1.1 7.3 ± 1.0 54 *
Sult1a1 18.1 10.5 ± 0.5 7.5 ± 0.7 7.7 *
Tnf 33.3 10.2 ± 0.8 13.9 ± 1.5 0.1 NS
Tspo 17.6 10.7 ± 2.8 5.4 ± 1.1 31 *
Detected at poor levels in some EAE samples
Il1b 26.2 Detected only in one EAE sample
Il15 23.4 Detected only in two EAE samples
Il15ra 22.9 Detected only in two EAE samples
Tnfrsf9 28.8 Detected only in one EAE sample
Tnfsf9 29.3 Detected only in one EAE sample
Detected at very poor levels in all samples
Cxcl12 24.6 13.9 ± 0.8 14.6 ± 1.7
Tgfb1 33.6 13.9 ± 1.1 18.2 ± 0.5
Ugt8a 30.1 12.7 ± 1.7 17.7 ± 0.4












Ct value for mixed tissue which contained liver, spleen, and brain cDNA indicated that the probes were effective in detecting the transcript. dCt values for control
and EAE correspond to the Ct value of the target gene minus the Ct geometric mean of the two housekeeping genes. For LCM-astrocyte samples, dCt values are
expressed as mean ± sem. Transcripts showing significant EAE-induced increased expression are in italics
NS p > 0.05, ¥ undetected in two of the three control samples (Ct value fixed to 38)
*p < 0.05
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functions including reactive oxygen species (ROS) gener-
ation. We found TSPO and DBI transcripts well expressed
in control astrocytes and further up-regulated in LCM-
reactive astrocytes (Table 3), indicating that TSPO/DBI
system is part of the astrocytic reactive signature during
autoimmune neuroinflammation. In line with these obser-
vations, TSPO and DBI transcript expressions have been
shown to be slightly increased in MS lesions [38], but the
cellular origin has not yet been described. The increased
osteopontin (SPP1) expression in EAE LCM-astrocytes
(Table 3) was somehow expected. We previously showed
SPP1 immunoreactivity in infiltrating cells, mainly CD11c
+ dendritic cells in late EAE [13], in agreement with previ-
ous reports showing osteopontin expression by macro-
phages/dendritic cells [39] but also by activated CCR2+
CCR5+ T cells [39] and B cells [40]. However, within the
extracellular compartment of the white matter lesions, we
previously observed a diffuse pattern of osteopontin
immunoreactivity that could come from extracellular
osteopontin secreted by immune cells and early reactive
astrocytes. Here, SPP1 transcript was clearly overex-
pressed in reactive astrocytes at EAE peak (5–6 days post
EAE onset). In line with these observations, osteopontin is
also already overexpressed in the normal appearing white
matter of MS brains and predominantly confined to astro-
cytes [41]. Finally, serpinG1 mRNA was found to be also
up-regulated in EAE LCM-astrocytes. Transcript for
serpinG1 (protease C1 inhibitor), a major regulator of the
classical complement, is drastically up-regulated in FACS-
sorted LPS-reactive murine astrocytes [11] and is also up-
regulated in spinal cord lesions of progressive MS [5].
Taken together, the transcriptomic profile of EAE reactive
astrocytes is consistent with a pro-inflammatory profile
(overexpression of TSPO, serpinG1, and SPP1; low mRNA
expression of arginase 1 and TGFβ, prototypic anti-
inflammatory markers). This is in contrast to ischemia
where cortical astrocytes exhibited a molecular pheno-
type suggesting that they may be protective [11]. We
do not exclude that, in the context of autoimmune in-
flammation, white matter astrocytes re-express other
molecules that would be beneficial as well. For ex-
ample, increased expression of nuclear Estrogen Recep-
tor α in reactive astrocytes has been shown to be
instrumental for estrogen-mediated beneficial effects on
EAE physiopathology [13, 42].
Chemokines
It is well established that several chemokines are also
expressed at low levels in resting astrocytes but are
induced in a variety of inflammatory conditions. We
looked at such prototypic chemokines whose expression
has been shown to be induced in the EAE spinal cord
tissue [3, 25, 26, 29, 43], in the MS brain [44–47], and inprimary astrocyte cultures treated with pro-inflammatory
cytokines [48–51]. Among tested chemokine transcripts,
CCL2 (SCYA2/MCP-1), CCL5 (SCYA5/RANTES), and
CCL7 (SCYA7/MCP-3), mRNA expressions were clearly
induced in EAE samples (Table 3). Reactive astrocytes
produce CCL2 in MS [46] as during EAE [13]. This ex-
pression is crucial for the recruitment of inflammatory
monocytes and myelin-degrading macrophages [52].
This up-regulation seems restricted to the white matter
astrocytes as it is not observed in gray matter during
chronic EAE (Table S3 in [13]) as well as in MS [53].
Similarly, CCL7 is only detected in reactive astrocytes
during EAE [42]. In line with these data, it has been
shown that CCL2, 5, 7, CXCL9 (SCYB9), and CXCL10
(SCYB10/IP-10) expression are highly dependent on
the inflammatory transcription factor NFkB and that
transgenic mice with specific deletion of NFKB signal-
ing in astrocytes exhibit decreased expression in those
chemokines and reduced CNS inflammatory response
during EAE [3, 4]. Thus, the high increase in these che-
mokine transcripts from our dissected astrocyte sam-
ples at the peak of EAE further validates our LCM
strategy. In contrast, CXCL12 was very poorly detected
in LCM-astrocytes, which is in agreement with the
preferential CXCL12 expression by endothelial cells in
this model [54], whereas in multiple sclerosis, CXCL12
is detected on blood vessels and astrocytes in chronic
inactive and early active lesions [55]. Among other che-
mokine transcripts up-regulated during EAE, we also
found CXCL16, whose expression and role in CNS in-
jury is not well defined. CXCL16 transcript in contrast
to previous chemokines was detected in control astrocytes
and moderately increased in EAE samples (Table 3).
CXCL16 is a transmembrane chemokine that can be
cleaved to a soluble form by ADAM metalloproteinases
and released by astrocytoma cells upon inflammatory con-
ditions [56]. CXCL16 transcript was found up-regulated
five-fold in spinal cord tissue in a slightly different murine
EAE model [43]. Cultured astrocytes express CXCL16
[56]; recent data in MS reported astrocytic CXCL16 ex-
pression [57] and that serum levels of CXCL16 reflect
disease activity [58]. The CXCL16 receptor, CXCR6, is
expressed by activated T cells and neutrophiles [59]
and is important, though not sufficient, for CNS T cell
infiltration or motility [60]. Administration of CXCL16
antibody in adoptive transfer EAE reduced mono-
nuclear cell trafficking and EAE symptoms [61]. How-
ever, recent data highlighted a neuroprotective role of
CXCL16 in a murine model of pMCAO [62]. The mech-
anism of action involved astrocytic release of CCL2, which
is rather deleterious for white matter during EAE as
stressed above. Whether the increase in astrocytic CXCL16
expression is deleterious or protective during MS needs
further investigation.
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We also looked for the expression of two classes of genes
involved in toxin and steroid inactivation by glucuronida-
tion (UGT enzymes) or sulfoconjugation (SULT enzymes).
None of the glucuronosyltransferases tested were expressed
in white matter LCM-astrocytes (Table 3), whereas they
were easily detected in the mixed tissue control that con-
tains liver, an organ rich in UGT and SULT enzymes.
Among all sulfotransferases, SULT1E1 and SULT1A1 are
the only enzymes having estrogen sulfonation activity.
Sult1e1 mRNA is not expressed in neural tissue [14]. We
could not detect it from mouse spinal cord cDNA (100 ng)
by Real-Time PCR (data not shown) nor was it detected
here in LCM-dissected astrocytes. We did not detect the
expression of other sulfotransferases such as the androgen
sulfotransferase Sult2a1 in LCM-dissected astrocytes. In
contrast, relative good signals were obtained for Sult1a1 in
control astrocytes, and the expression was further signifi-
cantly increased in EAE astrocytes (Table 3). Single Real-
Time PCR analysis of Sult1a1 transcripts from the whole
spinal cord cDNA (100 ng) confirmed up-regulation at day
postimmunization 16 (early EAE, 4.6 ± 0.1-fold) to day
postimmunization 28 (late EAE, 4.9 ± 0.6) as compared to
controls (n = 4/each group), indicating a sustained up-
regulation of the mRNA during this chronic EAE model.
Immunofluorescence performed on spinal cord sections
from control or EAE mice confirmed the specific expres-
sion of SULT1A1 in GFAP+ astrocytes; SULT1A1 antibody
effectively labeled cytoplasmic astrocytic fibers in the whiteFig. 3 Astrocytic SULT1A immunoreactivity in the EAE and control white m
control mouse (f–j and, for non-specific control, k–n). a, f SULT1A1 staining
green channel); b, g, l GFAP staining (red channel); c, h, m DAPI staining (blu
merged. o Schematic representation of the spinal cord section with approx
(GFAP+) cells (with identified nucleus) in (e) or to astrocytic GFAP+ fibers inmatter (Fig. 3). The difference in protein expression was
not as evident as for mRNA expression, but thick astrocytic
processes and white matter astrocytes were more easily de-
tected in EAE mice than in control mice in which most
fine astrocytic process appeared weakly labeled (Fig. 3).
Interestingly, we did not detect SULT1A1 immunoreactiv-
ity in astrocytes of the gray matter, where only some stain-
ing appeared restricted to a few neuronal nuclei (Fig. 4).
Immunohistochemistry on paraformaldehyde-perfused tis-
sue sections also identified similar pattern of immunoreac-
tivity with both SULT1A1 antibodies: low staining of
control astrocytic-like fibers and better visualization in
EAE samples of astrocytic-like fibers in the white matter
(Additional file 2: Figure S2). These data corroborate the
transcript analysis at the protein level. Taken together,
among the analyzed transcripts for sulfotransferases, the
expression of SULT1A1 in normal and reactive white mat-
ter (WM) astrocytes is peculiar. Moreover, any of the UGT
enzymes tested were found to be expressed in our astrocyte
TLDA analysis, suggesting that white matter astrocytes are
not well equipped to conjugate steroids and other sub-
strates by glucuronidation. Interestingly, Sult1a1 mRNA
was reported recently to be also induced in the spinal cord
tissue of Lewis rat in a model of acute EAE [26], but its cel-
lular origin was not determined. Moreover, when looking
at microarrays that have been previously performed on MS
tissue lesions, we found a report indicating that Sult1a1
transcript expression was two-fold increased in active le-
sions (three patients) but not in inactive lesions fromatter spinal cord. Representative stainings for EAE mouse (a–e) or
(green channel); k non-specific staining (no rabbit primary antibody,
e channel); d, i, n all channels merged; e, j red and green channels
imate field (red square) used for the pictures. Arrows point to astrocytic
(j). a–n Scale bar, 75 μm
Fig. 4 Lack of SULT1A1 immunoreactivity in astrocytes of the gray matter spinal cord. Representative stainings for EAE mouse (a–e) or control
mouse (f–j), and for non-specific control (k–n). a, f SULT1A1 staining (green channel); k, l non-specific staining in absence of rabbit and rat primary
antibodies (k, green channel; l, red channel); b, g GFAP staining (red channel); c, h, m DAPI staining (blue channel); d, i, n all channels merged;
e, j red and green channel merged. o Schematic representation of the spinal cord section with approximate field (red square) used for the pictures.
a–n Scale bar, 75 μm
Guillot et al. Journal of Neuroinflammation  (2015) 12:130 Page 11 of 14another patient (Supplementary 1 in [6]). Because all four
patients were analyzed for statistics, this up-regulation
did not reach significance and was not highlighted.
Nevertheless, this indicated that Sult1a1 transcript is
expressed in human CNS tissue and particularly in
active lesions that contains reactive astrocytes. Further
experiments will determine whether astrocytes are
involved as well in this up-regulation.
Conclusion
We present here for the first time a selected transcrip-
tomic (TLDA) profile from ex vivo LCM-WM astrocytes
from adult mouse spinal cord in controls and during
autoimmune neuroinflammation. Among the gene tran-
scripts analyzed that established a molecular signature
of WM reactive astrocytes, we highlighted here that
SULT1A1, an enzyme having estrogen inactivating ac-
tivity, is well expressed by the spinal cord WM astro-
cytes and further increased in EAE.
Whereas GFAP represents the best and widely used
astrocytic marker, the volume covered by the GFAP
staining is only 13 % of the volume of cortical protoplas-
tic astrocytes [63], highlighting the need for additional
astrocytic makers. Glutamate transporters GLAST-1
(EAAT1/ SLC1A3) and GLT-1 (EAAT2, SLC1A2) are
often used to label and select resting astrocytes for
in vitro studies or for transgenic mice [64, 65]. However,
their expression is down-regulated in several EAE models
[32, 66]. Moreover, these genes are also expressed inoligodendrocytes in human white matter [67] making
them poor markers for identifying reactive astrocytes dur-
ing neuroinflammation. Aldh1L1 is very specific to astro-
cytic populations but is drastically down-regulated in the
mature spinal cord compared to brain regions [65]. In fact,
in mouse brain gray matter, Sult1a1 transcript is highly
enriched in S100 promoter-driven GFP+ FACS-sorted
P16-17 astrocytes [10] as well as in adult Aldh1L1 ex-
pressing astrocytes [68]. Sult1a1 may thus be used as an
additional astrocytic marker for immunocytochemistry or
tracing studies in adult mouse. Our data indicate that, at
the protein level detected by conventional immunocyto-
chemistry or immunofluorescence, SULT1A1 in the spinal
cord is preferentially expressed in white matter astrocytes
(ventral, lateral and dorsal funiculi) as compared to gray
matter astrocytes. Similarly, we were unable to detect
SULT1A1 immunoreactivity in mouse cortical gray matter
astrocytes, whereas SULT1A1-immunoreactive astrocytes
could be detected in the white matter tracts of the fore-
brain (data not shown). Since SULT1A1 staining was
less intense as compared to GFAP, we cannot conclude
whether only a subpopulation of WM astrocytes ex-
presses SULT1A1. Further experiments at the single
cell level would be needed to address this point.
Recent studies have focused on radial glia and astro-
cytes as important steroid synthetic cells that provide ac-
tive neurosteroids for local neuroendocrine functions
and regulation of neurogenesis [69]. On the other hand,
studies on CNS tissues have highlighted decreases in the
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thesis in EAE [26] or MS [70]. In light of our observations,
as well as the reported Sult1a1 transcript expression in
MS active lesions [6] and the estrogen sulfonation activity
of SULT1A1, reactive astrocytes may have not only altered
sex steroid synthesis but also higher estrogen conjugation
activity, both potentially leading to lower intracellular con-
centrations active estrogen. Strikingly, white matter react-
ive astrocytes express nuclear estrogen receptor alpha
(ESR1) during EAE [13] as well as in MS active lesions
[38, 71], so they are well equipped to respond to low doses
of estrogen. However, only high nanomolar estrogen con-
centrations are effective in reducing ongoing EAE and
chemokine expression such as CCL2 [13]. Interestingly,
17α-ethinylestradiol (EE2), an estrogen commonly used in
oral contraceptives, acts as an inhibitor of SULT1A1 but
not as a substrate [72]. This may account for the effective-
ness of this compound when administrated after disease
onset to reduce murine EAE [73], whereas only high
nanomolar doses of the natural ligand 17β-estradiol are ef-
fective [13]. The astrocytic expression of SULT1A1, which
is further increased during EAE, may account for the rela-
tive resistance of this cell population to respond to ex-
ogenous low doses of 17β-estradiol. This may hold true as
well for MS astrocytes, an issue which now requires fur-
ther investigation because a recent MS clinical trial of a
17β-estradiol-based protocol starting at postpartum—to
prevent the increased risk of MS relapse observed at this
period—has been recently disappointing [74]. Finally, in
human, Sult1a1 polymorphisms [75] and copy number
variations [76] associated with differences in sulfonation
activity have been reported. Thus, large-scale genome-
wide association studies may also consider examining
Sult1a1 gene as previously highlighted [77]. This could
well apply to MS genomic studies.Additional files
Additional file 1: Figure S1. FACS analysis of EAE spinal cords used for
LCM. The lymphocytic infiltrates were composed mostly of CD4+ effector/
memory T cells and macrophages. A-E, Flow cytometric scattergrams of a
representative spinal cord cell suspension in the presence of myelin debris.
A, Side scatter showing the gating of leukocytes stained with DAPI and
excluding myelin debris. B, Example of CD45 and CD11b labelings on DAPI+
gated cells. Microglia are in green (CD45int CD11b+), macrophages
(CD45high CD11b + Ly6G-) and neutrophiles (CD45high CD11b + Ly6G+) in
yellow, and lymphocytes (CD45high CD11b-) in purple. C, Example of CD4
and CD8 labelings on CD3+ CD45high DAPI+ gated cells. D, Example of
CD19 and B220 labelings on CD45high DAPI gated cells. B220 (Q1 + Q2)
was used to select B cells in the lymphocyte population as CD19 antibody
gave poor signal (in contrast to a spleen cell control, data not shown). E,
Example of CD44 and CD62L labeling on CD45high CD3+ DAPI+ gated cells.
F, Corresponding results obtained for CD4+ and CD8+ T cells with naive
(CD44- CD62L+), central memory (CD44 + CD62L+) and effector/memory
(CD44 + CD62L-) phenotypes from the three mouse spinal cords (mean ±
sem). G. Summary of leukocyte populations (% of all CD45high cells) in the
three mouse EAE spinal cords (mean ± sem). H, Summary of lymphocytecomposition (% of CD45high CD11b- cells) in the three mouse EAE spinal
cords (mean ± sem).
Additional file 2: Figure S2. Immunohistochemistry for SULT1A1 in the
white matter spinal cord. DAB/peroxidase immunohistochemistry was
applied to detect SULT1A1 in sections from paraformaldehyde-perfused
female mice, using either Abcam or Bioss rabbit antibody as indicated for
each picture on the top left. The tissue that was used (control or EAE) is
indicated on the top right. SULT1A1 immunoreactivity is detected in
astrocyte/radial glia- like fibers of the white matter (vfu, ventral funiculus,
dfu, dorsal funiculus), especially on EAE samples. The pictures result from
identical time of acquisition. Adjacent sections were used to check for
GFAP staining using a rabbit antibody in corresponding areas. As positive
control, SULT1A1-immunoreactivity was detected in kidney tubules with
the two antibody tested. For the picture of the kidney assessing the lack
of non-specific (NS) staining -when no primary antibody was included in
the first incubation step-, differential interference contrast (DIC)/Nomarski
interference was added to see the unlabeled tubules. Scale bar, 60 μm
for spinal cord (SPC) or 100 μm for kidney.
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